SecSonar.com

Sonoma Pharmaceuticals, Inc. (SNOA)

Sonoma Pharmaceuticals, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Sonoma Pharmaceuticals, Inc. (SNOA) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $2M. Revenue grew 12.2% year-over-year and free cash flow was negative at -$168K. This page tracks SNOA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 10 employees · IPO Jan 25, 2007

Valuation

Valuation & price

$1.09 · as of May 17, 2026 · -79.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.64

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$5.35$3.19$1.03Jul 25Dec 25Jul 26Jul 7, 25$3.15Jul 9, 25$3.20Jul 11, 25$3.61Jul 15, 25$3.68Jul 17, 25$3.58Jul 21, 25$3.52Jul 23, 25$3.71Jul 25, 25$3.42Jul 29, 25$3.13Jul 31, 25$2.98Aug 4, 25$3.09Aug 6, 25$3.02Aug 11, 25$2.98Aug 13, 25$3.05Aug 15, 25$5.35Aug 19, 25$5.23Aug 21, 25$5.06Aug 25, 25$4.83Aug 27, 25$4.57Aug 29, 25$4.45Sep 3, 25$4.61Sep 5, 25$4.73Sep 9, 25$4.36Sep 11, 25$4.55Sep 16, 25$4.20Sep 18, 25$4.26Sep 22, 25$4.17Sep 24, 25$4.08Sep 26, 25$4.04Sep 30, 25$3.88Oct 2, 25$3.81Oct 6, 25$4.40Oct 8, 25$4.17Oct 10, 25$4.04Oct 14, 25$4.07Oct 16, 25$4.08Oct 21, 25$3.89Oct 23, 25$3.68Oct 27, 25$4.00Oct 29, 25$4.00Oct 31, 25$3.94Nov 4, 25$3.76Nov 6, 25$3.65Nov 10, 25$3.65Nov 12, 25$3.68Nov 14, 25$3.44Nov 18, 25$3.53Nov 20, 25$3.26Nov 25, 25$3.27Nov 28, 25$3.33Dec 2, 25$3.17Dec 4, 25$3.57Dec 8, 25$3.51Dec 10, 25$3.76Dec 12, 25$3.59Dec 16, 25$3.38Dec 18, 25$3.60Dec 22, 25$3.70Dec 24, 25$3.64Dec 29, 25$3.56Jan 2, 26$3.64Jan 6, 26$3.80Jan 8, 26$3.78Jan 12, 26$3.43Jan 14, 26$3.28Jan 16, 26$3.29Jan 21, 26$3.27Jan 23, 26$3.43Jan 27, 26$3.39Jan 29, 26$3.34Feb 2, 26$3.21Feb 4, 26$3.20Feb 9, 26$2.91Feb 11, 26$2.85Feb 13, 26$2.75Feb 18, 26$2.81Feb 20, 26$2.94Feb 24, 26$2.84Feb 26, 26$2.93Mar 2, 26$2.84Mar 4, 26$2.80Mar 6, 26$2.38Mar 10, 26$2.61Mar 12, 26$2.45Mar 17, 26$2.40Mar 19, 26$2.44Mar 23, 26$2.55Mar 25, 26$2.28Mar 27, 26$2.13Mar 31, 26$2.13Apr 2, 26$2.37Apr 7, 26$2.21Apr 9, 26$2.41Apr 13, 26$2.35Apr 15, 26$2.24Apr 17, 26$2.30Apr 22, 26$2.05Apr 24, 26$1.14Apr 28, 26$1.04Apr 30, 26$1.10May 4, 26$1.22May 6, 26$1.19May 8, 26$1.20May 12, 26$1.18May 14, 26$1.18May 18, 26$1.03May 20, 26$1.07May 22, 26$1.10May 28, 26$1.11Jun 1, 26$1.19Jun 3, 26$1.21Jun 5, 26$1.14Jun 9, 26$1.11Jun 11, 26$1.10Jun 15, 26$1.11Jun 17, 26$1.15Jun 22, 26$1.16Jun 24, 26$1.15Jun 26, 26$1.12Jul 2, 26$1.21
$1.0152-week range$5.35
Loading valuation history…

Fundamentals

Key fundamentals

$2M

Market cap

12.2%

Revenue growth (YoY)

38.3%

Gross margin

-$168K

Free cash flow (USD)

-$5.1M

Net debt

Net cash position

36.5%

Share dilution

1/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$9.4MFY 2017$12.8MFY 2018$16.7MFY 2019$19.0MFY 2020$17.9MFY 2021$18.6MFY 2022$12.6MFY 2023$13.3MFY 2024$12.7MFY 2025$14.3M
$9.4M$14.3M

Free cash flow by year

2016 → 2025

FY 2016$-9.1MFY 2017$-8.6MFY 2018$-12.6MFY 2019$-11.8MFY 2020$-4.8MFY 2021$-3.6MFY 2022$-4.4MFY 2023$-6.4MFY 2024$-2.4MFY 2025$-168.0K
-$9.1M-$168K

Gross margin by year

2021 → 2025

FY 202135.2%FY 202231.6%FY 202333.7%FY 202437.3%FY 202538.3%
35.2%38.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: Jun 16, 2026 (EPS $-0.09)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventStock Offering UpdateJun 18, 2026Filing
  • Annual report10-K FiledJun 16, 2026Filing
  • 8-K eventPublic Offering AnnouncedApr 30, 2026Filing
  • 8-K eventManufacturing Agreement SignedApr 9, 2026Filing

Questions

Frequently asked questions

What is Sonoma Pharmaceuticals, Inc.'s market cap?

Sonoma Pharmaceuticals, Inc. (SNOA) has a market capitalization of $2M.

What is SNOA's P/E ratio?

A meaningful P/E ratio is not available for SNOA — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is SNOA's price-to-book (P/B) ratio?

SNOA trades at 0.64 times book value per share.

When did Sonoma Pharmaceuticals, Inc. last report earnings?

SNOA last reported earnings on June 16, 2026; the next date is not yet scheduled.

Are insiders buying SNOA stock?

SEC Form 4 filings show no open-market insider buys at Sonoma Pharmaceuticals, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

UPC

Universe Pharmaceuticals Inc.

$1.8M

CPHI

China Pharma Holdings, Inc.

$2.4M

SBFM

Sunshine Biopharma, Inc.

$1.4M

SXTC

China SXT Pharmaceuticals, Inc.

$1.3M

IMCC

IM Cannabis Corp.

$1M

RDHL

RedHill Biopharma Ltd.

$3.1M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.